About Us
Knowledge Center
Podcast
Products and Services
My Products
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
About Us
Knowledge Center
Podcast
Products and Services
My Products
Home
Authors
Posts by Mark Painter and Jonathan Rubenstein, MD
Mark Painter and Jonathan Rubenstein, MD
43 POSTS
0 COMMENTS
2022 CMS proposed rule represents another mixed bag for urologists
Mark Painter and Jonathan Rubenstein, MD
-
August 5, 2021
TURP reimbursement denied due to misinterpretation of parenthetical attached to code
Mark Painter and Jonathan Rubenstein, MD
-
July 8, 2021
What are the reimbursement implications when a patient brings their own...
Mark Painter and Jonathan Rubenstein, MD
-
July 5, 2021
Questionnaires are not counted as tests under new E/M coding guidelines
Mark Painter and Jonathan Rubenstein, MD
-
June 29, 2021
Why CPT 38571 plus modifier 52 is recommended in this RALP...
Mark Painter and Jonathan Rubenstein, MD
-
May 25, 2021
Is 51798 appropriate for billing postvoid residual measured by catheterization?
Mark Painter and Jonathan Rubenstein, MD
-
May 18, 2021
How to incorporate data in your medical decision-making
Mark Painter and Jonathan Rubenstein, MD
-
May 17, 2021
What can you do about rising medical record review requests?
Mark Painter and Jonathan Rubenstein, MD
-
May 3, 2021
Can CPT 53899 be used to bill for mitomycin injection?
Mark Painter and Jonathan Rubenstein, MD
-
April 30, 2021
Lack of word “complete” in operative report results in payment denial
Mark Painter and Jonathan Rubenstein, MD
-
April 29, 2021
1
2
3
...
5
Page 2 of 5